• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cibus Announces the Election of Thomas Urban to Board of Directors

    4/15/26 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials
    Get the next $CBUS alert in real time by email

    SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the election of Thomas Urban to its Board of Directors.

    "We are pleased to welcome Tom to the Cibus Board of Directors," said Mark Finn, Chairman of the Board of Cibus. "As the Company pursues its commercialization initiatives, translating its trait pipeline into revenue producing relationships, Tom's experience building and scaling agribusiness will be highly valuable to our strategic planning and execution."

    Mr. Urban is the founder of Agribusiness Advisors, a firm he formed in 2013 focused on providing advisory, investment and entrepreneur support to early-stage companies focused on agriculture. Prior to forming Agribusiness Advisors, Mr. Urban was the chief executive officer of CellFor, Inc. from 2004 to 2012 when it was acquired by ArborGen, served in various leadership positions around the world from 1990 to 2002 with Pioneer Hi-Bred International, including after its acquisition by E.I. DuPont de Nemours in 1999, and began his career in mergers and acquisitions at Goldman, Sachs & Co. in 1988. Mr. Urban has also served as an entrepreneur in residence at the University of British Columbia since 2013. Mr. Urban received his undergraduate degree from Middlebury College and holds a Master of Business Administration from the Harvard Graduate School of Business.

    "It's an honor to join the Cibus Board to work alongside the team at the forefront of bringing the power of precision breeding to farmers around the world," said Mr. Urban. "There is a clear need for faster, more precise approaches to crop improvement, particularly as growers face increasing pressure on productivity and sustainability. Cibus has developed a platform that addresses both and I'm looking forward to contributing as the Company advances its commercial strategies."

    About Cibus

    Cibus is a leader in developing traits (characteristics) that address critical productivity, yield and sustainability challenges. Cibus' proprietary high-throughput gene editing technologies drive its long-term focus on productivity traits for farmers for the major global row crops. Cibus is not a seed company. It is a technology company that uses its gene editing technologies to develop plant traits at a fraction of the time and cost of conventional breeding and to license them to customers in exchange for royalties.

    Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of applicable securities laws, including The Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included herein, including statements regarding Cibus' operational and financial performance, Cibus' liquidity and capital resources, the implementation and execution of cost savings initiatives, Cibus' strategy, future operations, prospects, and plans, including the anticipated receipt of commercial revenues and additional funding and the achievement of commercial milestone targets, are forward-looking statements. Cibus' assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement. Because this involves such risks and uncertainties, the Company could use its available capital resources sooner than it currently expects. Forward-looking statements may be identified by words such as "anticipate," "believe," "intend," "expect," "plan," "scheduled," "could," "would" and "will," or the negative of these and similar expressions.

    CIBUS CONTACTS:

    INVESTOR RELATIONS

    Jeff Sonnek – ICR

    [email protected]

    MEDIA RELATIONS

    [email protected]

    Colin Sanford

    [email protected]



    Primary Logo

    Get the next $CBUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CBUS

    DatePrice TargetRatingAnalyst
    7/29/2024$25.00Buy
    Alliance Global Partners
    7/19/2024$22.00Buy
    Canaccord Genuity
    10/9/2023$25.00Buy
    H.C. Wainwright
    7/19/2023$30.00Buy
    Canaccord Genuity
    More analyst ratings

    $CBUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sauer Noel

    4 - Cibus, Inc. (0001705843) (Issuer)

    4/1/26 12:03:47 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Stokes Jason

    4 - Cibus, Inc. (0001705843) (Issuer)

    4/1/26 12:00:59 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Broos Carlo

    4 - Cibus, Inc. (0001705843) (Issuer)

    4/1/26 11:57:01 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    SEC Filings

    View All

    Cibus Inc. filed SEC Form 8-K: Leadership Update

    8-K - Cibus, Inc. (0001705843) (Filer)

    4/10/26 5:06:09 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 8-K filed by Cibus Inc.

    8-K - Cibus, Inc. (0001705843) (Filer)

    3/27/26 8:45:14 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    SEC Form 424B5 filed by Cibus Inc.

    424B5 - Cibus, Inc. (0001705843) (Filer)

    3/26/26 5:24:44 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cibus Announces the Election of Thomas Urban to Board of Directors

    SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the election of Thomas Urban to its Board of Directors. "We are pleased to welcome Tom to the Cibus Board of Directors," said Mark Finn, Chairman of the Board of Cibus. "As the Company pursues its commercialization initiatives, translating its trait pipeline into revenue producing relationships, Tom's experience building and scaling agribusiness will be highly valuable to our strategic planning and execution." Mr. Urban is the founder of Agribusiness Advisors, a firm he form

    4/15/26 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock

    SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the pricing of an underwritten public offering (the "Offering") of 6,976,744 shares of its Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") at a purchase price of $2.15 per share of Class A Common Stock. The Company has also granted the underwriter a 30-day option to purchase up to an additional 1,046,511 shares of Class A Common Stock to cover over-allotments, if any. All shares of Class A Common Stock to be sold in the Offering are to be sold by th

    3/26/26 6:55:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants

    SAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer shares of its Class A common stock, par value $0.0001 per share ("Class A Common Stock") and, in lieu of common stock to certain investors that so elect, pre-funded warrants to purchase additional shares of its Class A Common Stock in an underwritten public offering (the "Offering"). Cibus also expects to grant to the underwriter of the Offering a 30-day option to purchase up to an additional 15% of the shares of Class A Common Stock offered in the Off

    3/25/26 4:01:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners initiated coverage on Cibus Global with a new price target

    Alliance Global Partners initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    7/29/24 7:49:52 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Canaccord Genuity resumed coverage on Cibus Global with a new price target

    Canaccord Genuity resumed coverage of Cibus Global with a rating of Buy and set a new price target of $22.00

    7/19/24 8:34:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    H.C. Wainwright initiated coverage on Cibus Global with a new price target

    H.C. Wainwright initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

    10/9/23 8:32:05 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    $CBUS
    Leadership Updates

    Live Leadership Updates

    View All

    Cibus Announces the Election of Thomas Urban to Board of Directors

    SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the election of Thomas Urban to its Board of Directors. "We are pleased to welcome Tom to the Cibus Board of Directors," said Mark Finn, Chairman of the Board of Cibus. "As the Company pursues its commercialization initiatives, translating its trait pipeline into revenue producing relationships, Tom's experience building and scaling agribusiness will be highly valuable to our strategic planning and execution." Mr. Urban is the founder of Agribusiness Advisors, a firm he form

    4/15/26 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Announces the Election of Craig Wichner to Board of Directors

    SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the election of Craig Wichner to its Board of Directors. Mr. Wichner will also serve as a member of the Board's current Strategy Committee. "Craig brings an exceptional combination of financial acumen, strategic discipline, and industry insight to the Cibus Board," said Mark Finn, Chairman of the Board of Cibus. "As Cibus prepares for anticipated commercial scaling of our trait platform, Craig's expertise in sustainable growth and capital strategy in agriculture will be instrumental in strengthening our

    11/11/25 7:00:00 AM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Announces the Election of Kimberly A. Box to Board of Directors

    SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ: CBUS), a leading agricultural technology company developing and licensing advanced plant traits that enable higher yields, lower input costs, and more sustainable farming, today announced the election of Kimberly A. Box to its Board of Directors. "Kim brings to Cibus extensive leadership experience in technology and commercialization that will be invaluable as we sharpen our strategic commercialization efforts," said Mark Finn, Cibus Chairman. "Her understanding of market dynamics and experience in guiding innovation into scalable businesses will strengthen our strategic governance as we continue to drive long-term value c

    9/25/25 4:05:00 PM ET
    $CBUS
    $MGRC
    Agricultural Chemicals
    Industrials
    Diversified Commercial Services
    Consumer Discretionary

    $CBUS
    Financials

    Live finance-specific insights

    View All

    Cibus to Report Fourth Quarter 2025 Financial Results on March 17, 2026 After the Market Close and Host Conference Call

    SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report fourth quarter 2025 financial results on Tuesday, March 17, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Fourth Quarter 2025 Results Conference Call Event Date: Tuesday, March 17, 2026Time: 4:30 p.m. ETParticipant Numbers: +1-800-343-5172 (U.S.), +1-203-518-9856 (International)The conference ID "CIBUS" or 24287 will be required for entryEv

    3/3/26 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025

    With the addition of Centro Internacional de Agricultura Tropical (CIAT) in the quarter, Cibus now has 5 LATAM Rice customers as momentum continues toward achieving 2027 targeted initial LATAM Rice revenue On track to deliver HT traits to Latin American customer in Q4 2025 with field trials expected to commence by year end Engaged strategic growth advisory firm AgVayā to introduce Indian Rice growers to new solutions to scale crop productivity through advanced gene editing Successfully completed pre-commercial pilot runs for certain biofragrance products; commercial expansion targeted for 2026 Positive field trial results for HT2 in Canola in North America; HT2 and Sclerotinia resistance

    11/13/25 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials

    Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call

    SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report third quarter 2025 financial results on Thursday, November 13, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Third Quarter 2025 Results Conference Call Event Date: Thursday, November 13, 2025         Time: 4:30 p.m. ET         Participant Numbers: +1-800-274-8461 (U.S.), +1-203-518-9814 (International)The conference ID "CIBUS" or 24287 will

    10/30/25 4:05:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials